FDA Inspection 979212 — China Resources Saike Pharmaceutical Co., Ltd.
The FDA completed an inspection of China Resources Saike Pharmaceutical Co., Ltd. on Jun 24, 2016 in Beijing. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 24, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beijing (China)